Navigation Links
Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity
Date:8/16/2008

Hissey Kientz, LLP is concerned that despite a recent recall notice for the heart drug Digitek, the drug’s manufacturer has failed to provide any additional information on how long the heart medication was being improperly manufactured. According to a press release issued by the manufacturer, some Digitek tablets may have been manufactured at double their normal strength, meaning that patients could receive a double dose of the drug, leading to an overdose. A Digitek overdose could lead to severe side effects, including heart attack, stroke or death.

Austin, TX (Vocus) August 16, 2008 -- The law firm of Hissey Kientz, LLP is concerned over recent reports that many heart patients may not have been fully informed by the drug’s manufacturer about problems with the heart drug Digitek. Drugmaker Actavis Totowa issued a nationwide recall notice for the heart drug http://www.hkllp.com/digitek/digitek.html [Digitek] (digoxin) on April 25, 2008.

In a press release announcing the recall notice, the company stated that some Digitek tablets may have been manufactured at twice their normal thickness, meaning that patients could receive a double-dose of the drug. This increased exposure could cause patients to suffer an overdose, leading to heart attack, stroke or death.

But according to a statement by the Food and Drug Administration published on May 1, 2008, since the Digitek recall was issued doctors and patients have received no additional information on how long the drug was being produced at twice the normal strength. The public has also not been notified on how many lots of the heart medication were improperly manufactured and when this problem was first detected.

“Actavis has a responsibility to provide consumers with all the available safety information about the manufacturing problems connected with the http://www.hkllp.com/digitek/digitek-recall.html [Digitek recall],” says attorney Mike Hissey with Hissey Kientz, LLP in Austin, Texas. “The public has a right to know how long this problem has been going on and how many patients could be affected. Many consumers were only made aware of the problems with Digitek when their pharmacist or doctor told them about the recall notice.”

Digitek is prescribed to patients with heart problems in order to treat congestive heart failure, an irregular heartbeat or other symptoms. Digitek is a form of the heart medication digitalis, which helps to strengthen the beating of the heart muscles and relieve the symptoms of patients with these conditions. It is also known generically as digoxin.

However, when administered in too high of a dose, digoxin drugs such as Digitek may cause digoxin toxicity, resulting in an overdose. Symptoms of a http://www.hkllp.com/digitek/digitek-side-effects.html [Digitek overdose] include unusual changes in vision, dizziness, irregular heartbeat, abnormally low blood pressure or heart rate, nausea, vomiting or other symptoms. In severe cases, digoxin toxicity can lead to a heart attack or stroke, which can result in death.

The FDA sent warning letters to Actavis in September 2006 and February 2007 after the agency uncovered manufacturing problems at the plant where Digitek is produced. The FDA stated in these letters that because of quality control problems at the plant, drugs made there were “adulterated,” making it impossible to determine if they were being manufactured at the correct strength.

Actavis also issued a recall notice on August 1, 2008 for every single drug produced at the New Jersey plant where Digitek was manufactured. The recall notices were issued after an FDA inspection earlier this year revealed that the company had continued to violate “standards for good manufacturing practices,” according to a statement by the company, even after it had received two previous warning letters for similar infractions.

Digitek tablets manufactured by Actavis Totowa were distributed by UDL Laboratories and Mylan Pharmaceuticals. Tablets distributed by UDL were sold under the label “UDL,” while those distributed by Mylan were sold under the name “Bertek.” Patients who were taking Digitek before the recall notice was issued may wish to speak with their doctors to discuss alternate forms of treatment.

Dozens of patients who suffered severe injuries after using Digitek have filed lawsuits against the manufacturer and distributors of the drug. These lawsuits have alleged that Digitek was dangerously and defectively manufactured, putting patients at risk of severe and potentially fatal side effects due to an overdose.

About Hissey Kientz, LLP
http://www.hkllp.com/ [Hissey Kientz, LLP] is currently accepting cases involving individuals who may have been injured as a result of a Digitek overdose. Hissey Kientz, LLP also represents those who contracted mesothelioma or lung cancer as a result of asbestos exposure, and those injured by the Ortho Evra patch, Trasylol, the Composix Kugel mesh patch, the Duragesic patch (fentanyl), gadolinium MRI contrast dyes or other defective drugs and devices. To learn more about the firm and other drug cases, visit Hissey Kientz, LLP (www.hkllp.com) or call toll-free at (866) 275-4454.

###

Read the full story at http://www.prweb.com/releases///prweb1190604.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
2. AGD Concerned With Presidential Veto of SCHIP Reauthorization Bill
3. National Nature Made(R) Survey Finds U.S. Adults Are Concerned About Heart Disease but May not be Managing Their Risk
4. AACN Concerned That the Presidents FY 2009 Budget Request Will Prolong the Nursing and Nurse Faculty Shortage
5. New Survey Shows African-Americans Are Concerned With Heart Health but Unaware of Link to Brain Health
6. National Religious Coalition Deeply Concerned by HHS Secretarys Disregard for Womens Reproductive Health
7. Operating Room Nurses are Concerned about Complications Associated with Powdered Gloves
8. UNICEF Concerned About Emotional Distress of Children in Myanmar
9. Survey: Maryland Voters Concerned About Health Care
10. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
11. Comparison of obstetric outcomes between on-call and patients own obstetricians
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity
(Date:3/24/2017)... ... March 24, 2017 , ... The iaedp Foundation, the premier provider ... caring for those suffering from the full spectrum of disordered eating, announced today that ... professionals from nearly all 50 states and several countries converged on the Green Valley ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... Sedona, Arizona’s Premier Center for Shamanic Healing and Spiritual Awakening, proudly presents ... June 9--24, 2017. This sacred and spiritual journey during the Summer Solstice ...
(Date:3/24/2017)... ... March 24, 2017 , ... As ... to create a communications platform that positions them as the go-to thought leader ... reinvented their online publication as an always-on, always-fresh news, views and advocacy engine, ...
(Date:3/24/2017)... ... March 24, 2017 , ... On June ... ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She will present on: ... of cases litigated under ERISA involve claims for long-term disability benefits. This ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... Viewers who ... variety of critical historical facts, cultural practices, goods, services, and societal issues tend to ... will look into the popular practice of utilizing running events for causes around the ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , March 24, 2017 New England ... recipient of an award including funding and in-kind service ... draw technology.  "Making blood draws less ... making their whole hospital experience better.  We,re looking forward ... technology can help improve care for the kids we ...
(Date:3/24/2017)... YORK , March 24, 2017   ... leading organization within medical affairs in the pharmaceutical ... as the chair of a newly formed scientific ... board members to form the first ever medical ... For more information about the ACMA, please ...
(Date:3/24/2017)... Research and Markets has announced the addition ... - 2035" report to their offering. ... The Deep Learning: Drug Discovery and Diagnostics ... the growing market of deep learning solutions within the healthcare domain. ... emerged as a novel solution to generate relevant insights from medical ...
Breaking Medicine Technology: